Acute chest pain is a common presentation in clinical practice, often posing diagnostic challenges for clinicians due to its diverse etiologies. A comprehensive approach is necessary to accurately identify the underlying cause and initiate appropriate management.
Initial evaluation should focus on identifying life-threatening conditions such as acute coronary syndromes, pulmonary embolism, and aortic dissection. A thorough history, physical examination, and appropriate investigations, including ECG, troponin levels, and chest imaging, are crucial in this phase.
Patients with acute chest pain should be stratified based on their risk of adverse events. Tools such as the HEART score or the GRACE score can aid in this process. High-risk patients require immediate intervention, while low-risk patients may undergo further diagnostic testing.
Management should be tailored to the underlying cause of chest pain. In acute coronary syndromes, strategies may include pharmacotherapy, percutaneous coronary intervention, or coronary artery bypass grafting. Other conditions may necessitate different approaches, such as anticoagulation in pulmonary embolism or surgical intervention in aortic dissection.
Long-term follow-up is essential in patients presenting with acute chest pain. This includes lifestyle modification, medication adherence, and regular monitoring for recurrence of symptoms or development of complications.
In conclusion, acute chest pain requires a comprehensive approach for effective management in clinical practice. This includes a thorough initial evaluation, risk stratification, tailored management strategies, and long-term follow-up. By adopting such an approach, clinicians can improve patient outcomes and minimize complications associated with this common clinical presentation.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation